Helius Medical Technologies to Present at the 2023 Interdisciplinary Association of Functional Neuroscience and Rehabilitation ConferenceGlobeNewsWire • 09/13/23
How Much Upside is Left in Helius Medical Technologies, Inc. (HSDT)? Wall Street Analysts Think 1183.3%Zacks Investment Research • 09/06/23
Helius Medical Technologies, Inc. Compliant with All Applicable Nasdaq Listing CriteriaGlobeNewsWire • 09/05/23
Helius Medical Technologies, Inc. (HSDT) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/10/23
Helius Medical Technologies, Inc. Reports Second Quarter 2023 Financial ResultsGlobeNewsWire • 08/10/23
Helius Medical Technologies, Inc. Announces Participation of Montefiore Medical Center in its PoNS® Therapeutic Experience ProgramGlobeNewsWire • 08/07/23
Helius Medical Technologies, Inc. to Release Second Quarter 2023 Financial Results on August 10, 2023GlobeNewsWire • 08/02/23
Helius Medical Technologies, Inc. Expands Stroke Trial at the Medical University of South CarolinaGlobeNewsWire • 07/27/23
Helius Medical Technologies to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-VestGlobeNewsWire • 06/14/23
Helius to Highlight Innovative PoNS Therapy™ at the 2023 Consortium of Multiple Sclerosis Centers Annual Meeting, in Commemoration of World MS DayGlobeNewsWire • 05/24/23
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)GlobeNewsWire • 05/19/23
Helius Medical Technologies, Inc. Reports First Quarter 2023 Financial ResultsGlobeNewsWire • 05/11/23
Helius Medical Technologies, Inc. to Release First Quarter 2023 Financial Results on May 11, 2023GlobeNewsWire • 05/04/23
Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685GlobeNewsWire • 04/17/23
Helius Medical Technologies, Inc. Announces Distribution of Series B Preferred Stock to Holders of its Class A Common Stock Intended to Facilitate a Reverse Stock Split, if NecessaryGlobeNewsWire • 03/23/23
Helius Medical Technologies and HealthTech Connex Announce Exclusive Distribution Agreement for the Portable Neuromodulation Stimulator (PoNS®) DeviceGlobeNewsWire • 03/22/23
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewsWire • 03/09/23